These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37851433)

  • 1. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story.
    Guitart J
    JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis.
    Chiba T; Nagai T; Osada SI; Manabe M
    Acta Derm Venereol; 2019 Jul; 99(9):818-819. PubMed ID: 31045233
    [No Abstract]   [Full Text] [Related]  

  • 3. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
    Joshi TP; Duvic M
    J Am Acad Dermatol; 2023 Jun; 88(6):e305-e306. PubMed ID: 36858155
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
    Ayasse M; Nelson K; Glass F; Silverberg JI
    Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
    Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.
    Jfri A; Smith JS; Larocca C
    J Am Acad Dermatol; 2023 May; 88(5):1164-1166. PubMed ID: 36481378
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of Mycosis Fungoides after Dupilumab Treatment for Atopic Dermatitis.
    O'Neill L; Duffy RF; Manders SM
    Skinmed; 2023; 21(2):105-106. PubMed ID: 37158349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing mycosis fungoides after initiation of therapy with dupilumab: a case report and literature review.
    Yan D; Ramachandran V; Weston G; Kim RH; Latkowski JA
    Int J Dermatol; 2023 Sep; 62(9):e500-e503. PubMed ID: 36946434
    [No Abstract]   [Full Text] [Related]  

  • 9. Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides.
    Kwong YL
    Ann Hematol; 2014 Apr; 93(4):713-4. PubMed ID: 23934231
    [No Abstract]   [Full Text] [Related]  

  • 10. Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.
    Wang J; Ram-Wolff C; Dobos G; Al Hage J; Grange F; Rivet J; Vignon-Pennamen MD; Moins-Teisserenc H; Boisson M; Moegle C; Sadoux A; Mourah S; Battistella M; Bagot M; de Masson A
    Br J Dermatol; 2022 Jul; 187(1):129-131. PubMed ID: 35083741
    [No Abstract]   [Full Text] [Related]  

  • 11. Severely pruritic mycosis fungoides successfully treated with upadacitinib.
    Kook H; Park SY; Hong N; Lee DH; Jung HJ; Park MY; Ahn J
    J Dtsch Dermatol Ges; 2024 Mar; 22(3):450-451. PubMed ID: 38326084
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides.
    Fountain E; Mistry H; Jain P; Duvic M; Fowler N
    Leuk Lymphoma; 2019 Apr; 60(4):1079-1082. PubMed ID: 30301395
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
    Postorino M; Pupo L; Provenzano I; Del Principe MI; Buccisano F; Franceschini L; Rizzo M; Nasso D; Meconi F; Onnis I; Vaccarini S; Zizzari A; Anemona L; Mauramati S; Bruno E; Cantonetti M; Amadori S
    Ann Hematol; 2016 Jan; 95(1):153-154. PubMed ID: 26442854
    [No Abstract]   [Full Text] [Related]  

  • 14. Folliculotropic mycosis fungoides associated with atopic dermatitis.
    Zhou H; Luo ZD; Tang XH; Han JD; Gao Q
    Australas J Dermatol; 2018 May; 59(2):e143-e145. PubMed ID: 28731507
    [No Abstract]   [Full Text] [Related]  

  • 15. Dupilumab-associated mycosis fungoides: a cross-sectional study.
    Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
    Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis Fungoides in 2 Pediatric Patients with Atopic Dermatitis.
    Young GJ; Luu M; Izadi N
    J Allergy Clin Immunol Pract; 2021 May; 9(5):2068-2069. PubMed ID: 33727009
    [No Abstract]   [Full Text] [Related]  

  • 17. Progression of mycosis fungoides after treatment with dupilumab: A case report.
    Miyashiro D; Vivarelli AG; Gonçalves F; Cury-Martins J; Sanches JA
    Dermatol Ther; 2020 Nov; 33(6):e13880. PubMed ID: 32558148
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycosis fungoides presenting as pigmented purpuric dermatitis.
    Hanna S; Walsh N; D'Intino Y; Langley RG
    Pediatr Dermatol; 2006; 23(4):350-4. PubMed ID: 16918631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides? Sezary syndrome.
    Roenigk HH; Taylor JG
    Arch Dermatol; 1970 Feb; 101(2):244-6. PubMed ID: 4244178
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy.
    Jour G; Aung PP; Merrill ED; Curry JL; Tetzlaff MT; Nagarajan P; Ivan D; Prieto VG; Duvic M; Miranda RN; Torres-Cabala CA
    J Dermatol Sci; 2018 Jan; 89(1):88-91. PubMed ID: 29030090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.